|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2011-4-25
|
|
pubmed:abstractText |
Sirolimus-eluting stents (SES) are widely used in coronary artery disease as revascularization therapy. Although endothelial dysfunction induced by implanted SES can become a major clinical concern, therapeutic strategies to overcome this disorder remain unclear. The aim of the present study was therefore to identify effective therapies in a clinically relevant animal model.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1347-4820
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
25
|
|
pubmed:volume |
75
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1098-106
|
|
pubmed:meshHeading |
pubmed-meshheading:21383515-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:21383515-Animals,
pubmed-meshheading:21383515-Antihypertensive Agents,
pubmed-meshheading:21383515-Benzimidazoles,
pubmed-meshheading:21383515-Coronary Vessels,
pubmed-meshheading:21383515-Drug Therapy, Combination,
pubmed-meshheading:21383515-Drug-Eluting Stents,
pubmed-meshheading:21383515-Endothelium, Vascular,
pubmed-meshheading:21383515-Hypoglycemic Agents,
pubmed-meshheading:21383515-Inflammation,
pubmed-meshheading:21383515-Protective Agents,
pubmed-meshheading:21383515-Sirolimus,
pubmed-meshheading:21383515-Sus scrofa,
pubmed-meshheading:21383515-Tetrazoles,
pubmed-meshheading:21383515-Thiazolidinediones,
pubmed-meshheading:21383515-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Candesartan with pioglitazone protects against endothelial dysfunction and inflammatory responses in porcine coronary arteries implanted with sirolimus-eluting stents.
|
|
pubmed:affiliation |
Department of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
